Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > well just maybe

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Oct 26, 2023 10:38am

163 Views

Post# 35702043

RE:RE:RE:RE:RE:RE:RE:RE:well just maybe

There was an article ~5 years or so ago posted on this board about the growth of the nmibc market by now. Market sales were to be between $500Mil and $1Bil US per year. So, assuming raw sales on the ~15% late stage share of this available to TLT, I estimated $8 a share value. Using a conservative x16 of raw sales, not EBITA. It might be slightly more or less than that now with more dilution, maybe the market is actually larger than those estimates?

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China